Mike Mensinger's Insider Trades & SAST Disclosures
Mike Mensinger's most recent trade in Beta Bionics Inc. was a trade of 52,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mike Mensinger.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 94,019 | - | 0 | Common Stock | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 236,553 | 236,553 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 31 Jan 2025 | 33,350 | 59,019 | - | 17 | 566,950 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 0 | - | - | Series D Preferred Stock | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 15,107 | - | - | Common Stock | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 0 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 10,575 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 25,682 | - | 0.0 | 212 | Common Stock | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 31 Jan 2025 | 13 | 25,669 | - | 17 | 221 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges